References

  1. Helmick CG, Felson DT, Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008 Jan;58(1):15-25. doi: 10.1002/art.23177.
  2. Mercado FB, Marshall RI, Klestov AC, et al. Relationship between rheumatoid arthritis and periodontitis. J Periodontol. 2001 Jun;72(6):779-87. doi: 10.1902/jop.2001.72.6.779.
  3. Havemose-Poulsen A, Westergaard J, Stoltze K, et al. Periodontal and hematological characteristics associated with aggressive periodontitis, juvenile idiopathic arthritis, and rheumatoid arthritis. J Periodontol. 2006 Feb;77(2):280-8. doi: 10.1902/jop.2006.050051.
  4. Pischon N, Pischon T, Kröger J, et al. Association among rheumatoid arthritis, oral hygiene, and periodontitis. J Periodontol. 2008 Jun;79(6):979-86. doi: 10.1902/jop.2008.070501.
  5. Dissick A, Redman RS, Jones M, et al. Association of periodontitis with rheumatoid arthritis: a pilot study. J Periodontol. 2010 Feb;81(2):223-30. doi: 10.1902/jop.2009.090309.
  6. Mercado F, Marshall RI, Klestov AC, et al. Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol. 2000 Apr;27(4):267-72.
  7. Cantley MD, Haynes DR, Marino V, et al. Pre-existing periodontitis exacerbates experimental arthritis in a mouse model. J Clin Periodontol. 2011 Jun;38(6):532-41. doi: 10.1111/j.1600-051X.2011.01714.x. Epub 2011 Mar 21.
  8. Mercado FB, Marshall RI, Bartold PM. Inter-relationships between rheumatoid arthritis and periodontal disease. A review. J Clin Periodontol. 2003 Sep;30(9):761-72.
  9. Han JY, Reynolds MA. Effect of anti-rheumatic agents on periodontal parameters and biomarkers of inflammation: a systematic review and meta-analysis. J Periodontal Implant Sci. 2012 Feb;42(1):3-12. doi: 10.5051/jpis.2012.42.1.3. Epub 2012 Feb 29.
  10. Mayer Y, Balbir-Gurman A, Machtei EE. Anti-tumor necrosis factor-alpha therapy and periodontal parameters in patients with rheumatoid arthritis. J Periodontol. 2009 Sep;80(9):1414-20. doi: 10.1902/jop.2009.090015.
  11. Kobayashi T, Okada M, Ito S, et al. Assessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis. J Periodontol. 2014 Jan;85(1):57-67. doi: 10.1902/jop.2013.120696. Epub 2013 Mar 14.
  12. Okada M, Kobayashi T, Ito S, et al. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis. J Periodontol. 2013 Dec;84(12):e74-84. doi: 10.1902/jop.2013.130079. Epub 2013 May 23.
  13. Silvestre FJ, Silvestre-Rangil J, Bagán L, et al. Effect of nonsurgical periodontal treatment in patients with periodontitis and rheumatoid arthritis: A systematic review. Med Oral Patol Oral Cir Bucal. 2016 May 1;21(3):e349-54.
  14. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315-24.
  15. Harris ED Jr. Clinical features of rheumatoid arthritis. In: Textbook of rheumatology, eds. Kelly WN, Harris ED, and Sledge CB. 5th edition. p. 898. Philadelphia, PA: WB Saunders.
  16. O'Sullivan JB, Cathcart ES. The prevalence of rheumatoid arthritis. Follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts. Ann Intern Med. 1972 Apr;76(4):573-7.
  17. Pincus T, Marcum SB, Callahan LF, et al. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: I. Nonsteroidal antiinflammatory drugs. J Rheumatol. 1992 Dec;19(12):1874-84.
  18. Pincus T, Marcum SB, Callahan LF. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J Rheumatol. 1992 Dec;19(12):1885-94.
  19. Sherrer YS, Bloch DA, Mitchell DM, et al. The development of disability in rheumatoid arthritis. Arthritis Rheum. 1986 Apr;29(4):494-500.
  20. Roberts WN, Daltroy LH, Anderson RJ. Stability of normal joint findings in persistent classic rheumatoid arthritis. Arthritis Rheum. 1988 Feb;31(2):267-71.
  21. Calin A, Elswood J, Klouda PT. Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. Arthritis Rheum. 1989 Oct;32(10):1221-5.
  22. van Zeben D, Breedveld FC. Prognostic factors in rheumatoid arthritis. J Rheumatol Suppl. 1996 Mar;44:31-3.
  23. Izui S, Eisenberg RA, Dixon FJ. IgM rheumatoid factors in mice injected with bacterial lipopolysaccharides. J Immunol. 1979 May;122(5):2096-102.
  24. Phillips PE. Evidence implicating infectious agents in rheumatoid arthritis and juvenile rheumatoid arthritis. Clin Exp Rheumatol. 1988 Jan-Mar;6(1):87-94.
  25. Venables PJ. Infection and rheumatoid arthritis. Curr Opin Rheumatol. 1989 Jun;1(1):15-20.
  26. Nishioka K, Sumida T, Hasunuma T. et al. Human T lymphotrophic virus type I in arthopathy and autoimmune disorders. Arthritis & Rheumatism. 1996 Aug;39(8):1410-1418. Accessed January 10, 2017.
  27. Wegner N, Wait R, Sroka A, et al. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum. 2010 Sep;62(9):2662-72. doi: 10.1002/art.27552.
  28. Bartold PM, Marino V, Cantley M, et al. Effect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. J Clin Periodontol. 2010 May;37(5):405-11. doi: 10.1111/j.1600-051X.2010.01552.x.
  29. van den Broek MF, van den Berg WB, Arntz OJ, et al. Reaction of bacterium-primed murine T cells to cartilage components: a clue for the pathogenesis of arthritis? Clin Exp Immunol. 1988 Apr;72(1):9-14.
  30. Flemmig TF. Periodontitis. Ann Periodontol. 1999 Dec;4(1):32-8.
  31. Page RC, Schroeder HE. Pathogenesis of inflammatory periodontal disease. A summary of current work. Lab Invest. 1976 Mar;34(3):235-49.
  32. Löe H, Anerud A, Boysen H, et al. Natural history of periodontal disease in man. Rapid, moderate, and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol 1986; May 13(5):431-440.
  33. Socransky SS, Haffajee AD, Goodson JM, et al. New concepts of destructive periodontal disease. J Clin Periodontol. 1984 Jan;11(1):21-32.
  34. Jeffcoat MK, Reddy MS. Progression of probing attachment loss in adult periodontitis. J Periodontol. 1991 Mar;62(3):185-9. doi: 10.1902/jop.1991.62.3.185.
  35. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999 Dec;4(1):1-6. doi: 10.1902/annals.1999.4.1.1.
  36. American Academy of Periodontology Task Force Report on the Update to the 1999 Classification of Periodontal Diseases and Conditions. J Periodontol. 2015 Jul;86(7):835-8. doi: 10.1902/jop.2015.157001. Epub 2015 May 27.
  37. Eke PI, Dye BA, Wei L, et al. Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res. 2012 Oct;91(10):914-20. Epub 2012 Aug 30.
  38. Eke PI, Wei L, Thornton-Evans GO, et al. Risk Indicators for Periodontitis in US Adults: National Health and Nutrition Examination Survey (NHANES) 2009 to 2012. J Periodontol. 2016 Oct;87(10):1174-85. doi: 10.1902/jop.2016.160013. Epub 2016 Jul 1.
  39. Eke PI, Dye BA, Wei L, et al. Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. J Periodontol. 2015 May;86(5):611-22. doi: 10.1902/jop.2015.140520. Epub 2015 Feb 17.
  40. Hirschfeld L, Wasserman B. A long-term survey of tooth loss in 600 treated periodontal patients. J Periodontol. 1978 May;49(5):225-37. doi: 10.1902/jop.1978.49.5.225.
  41. McFall WT Jr. Tooth loss in 100 treated patients with periodontal disease. A long-term study. J Periodontol. 1982 Sep;53(9):539-49. doi: 10.1902/jop.1982.53.9.539.
  42. Löe H, Anerud A, Boysen H, et al. The natural history of periodontal disease in man. The rate of periodontal destruction before 40 years of age. J Periodontol. 1978 Dec;49(12):607-20. doi: 10.1902/jop.1978.49.12.607.
  43. Michalowicz BS, Aeppli DP, Kuba RK, et al. A twin study of genetic variation in proportional radiographic alveolar bone height. J Dent Res. 1991 Nov;70(11):1431-5.
  44. Michalowicz BS, Aeppli D, Virag JG,et al. Periodontal findings in adult twins. J Periodontol. 1991 May;62(5):293-9. doi: 10.1902/jop.1991.62.5.293.
  45. Alley CS, Reinhardt RA, Maze CA, et al. HLA-D and T lymphocyte reactivity to specific periodontal pathogens in type 1 diabetic periodontitis. J Periodontol. 1993 Oct;64(10):974-9. doi: 10.1902/jop.1993.64.10.974.
  46. Bergström J, Preber H. Tobacco use as a risk factor. J Periodontol. 1994 May;65(5 Suppl):545-50. doi: 10.1902/jop.1994.65.5s.545.
  47. Hart TC, Shapira L, Van Dyke TE. Neutrophil defects as risk factors for periodontal diseases. J Periodontol. 1994 May;65(5 Suppl):521-9. doi: 10.1902/jop.1994.65.5s.521.
  48. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. 1997 Jan;24(1):72-7.
  49. Lundberg K, Wegner N, Yucel-Lindberg T, et al. Periodontitis in RA-the citrullinated enolase connection. Nat Rev Rheumatol. 2010 Dec;6(12):727-30. doi: 10.1038/nrrheum.2010.139. Epub 2010 Sep 7.
  50. Kaur S, White S, Bartold PM. Periodontal disease and rheumatoid arthritis: a systematic review. J Dent Res. 2013 May;92(5):399-408. doi: 10.1177/0022034513483142. Epub 2013 Mar 22.
  51. Socransky SS, Haffajee AD, Cugini MA, et al. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998 Feb;25(2):134-44.
  52. Hajishengallis G, Liang S, Payne MA, et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. Cell Host Microbe. 2011 Nov 17;10(5):497-506. doi: 10.1016/j.chom.2011.10.006. Epub 2011 Oct 27.
  53. Guo Y, Nguyen KA, Potempa J. Dichotomy of gingipains action as virulence factors: from cleaving substrates with the precision of a surgeon's knife to a meat chopper-like brutal degradation of proteins. Periodontol 2000. 2010 Oct;54(1):15-44. doi: 10.1111/j.1600-0757.2010.00377.x.
  54. Krauss JL, Potempa J, Lambris JD, et al. Complementary Tolls in the periodontium: how periodontal bacteria modify complement and Toll-like receptor responses to prevail in the host. Periodontol 2000. 2010 Feb;52(1):141-62. doi: 10.1111/j.1600-0757.2009.00324.x.
  55. Potempa M, Potempa J. Protease-dependent mechanisms of complement evasion by bacterial pathogens. Biol Chem. 2012 Sep;393(9):873-88. doi: 10.1515/hsz-2012-0174.
  56. Liu YC, Lerner UH, Teng YT. Cytokine responses against periodontal infection: protective and destructive roles. Periodontol 2000. 2010 Feb;52(1):163-206. doi: 10.1111/j.1600-0757.2009.00321.x.
  57. Kassem A, Henning P, Lundberg P, Souza PP, Lindholm C, Lerner UH. Porphyromonas gingivalis Stimulates Bone Resorption by Enhancing RANKL (Receptor Activator of NF-κB Ligand) through Activation of Toll-like Receptor 2 in Osteoblasts. J Biol Chem. 2015 Aug 14;290(33):20147-58. doi: 10.1074/jbc.M115.655787. Epub 2015 Jun 17.
  58. György B, Tóth E, Tarcsa E, et al. Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol. 2006;38(10):1662-77. doi: 10.1016/j.biocel.2006.03.008. Epub 2006 Mar 30.
  59. Wang Y, Li M, Stadler S, et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. 2009 Jan 26;184(2):205-13. doi: 10.1083/jcb.200806072. Epub 2009 Jan 19.
  60. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet. 2009 Feb 21;373(9664):659-72. doi: 10.1016/S0140-6736(09)60008-8. Epub 2009 Jan 20.
  61. Klareskog L, Rönnelid J, Lundberg K, et al. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol. 2008;26:651-75. doi: 10.1146/annurev.immunol.26.021607.090244.
  62. Wegner N, Lundberg K, Kinloch A, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev. 2010 Jan;233(1):34-54. doi: 10.1111/j.0105-2896.2009.00850.x.
  63. Bartold PM, Marino V, Cantley M, et al. Effect of Porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. J Clin Periodontol. 2010 May;37(5):405-11. doi: 10.1111/j.1600-051X.2010.01552.x.
  64. Demmer RT, Molitor JA, Jacobs DR Jr, et al. Periodontal disease, tooth loss and incident rheumatoid arthritis: results from the First National Health and Nutrition Examination Survey and its epidemiological follow-up study. J Clin Periodontol. 2011 Nov;38(11):998-1006. doi: 10.1111/j.1600-051X.2011.01776.x. Epub 2011 Sep 13.
  65. Liao F, Li Z, Wang Y, et al. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis. Med Hypotheses. 2009 Jun;72(6):732-5. doi: 10.1016/j.mehy.2008.12.040. Epub 2009 Feb 25.
  66. Hitchon CA, Chandad F, Ferucci ED, et al. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol. 2010 Jun;37(6):1105-12. doi: 10.3899/jrheum.091323. Epub 2010 May 1.
  67. Kharlamova N, Jiang X, Sherina N, et al. Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology. Arthritis Rheumatol. 2016 Mar;68(3):604-13. doi: 10.1002/art.394911.
  68. Mikuls TR, Payne JB, Yu F, et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014 May;66(5):1090-100. doi: 10.1002/art.38348.
  69. Arvikar SL, Collier DS, Fisher MC, et al. Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis. Arthritis Res Ther. 2013;15(5):R109
  70. Chimenti MS, Triggianese P, Conigliaro P, et al. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Dis. 2015 Sep 17;6:e1887. doi: 10.1038/cddis.2015.246.
  71. Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol. 2015 Jan;15(1):30-44. doi: 10.1038/nri3785.
  72. Nesse W, Abbas F, van der Ploeg I, et al. Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol. 2008 Aug;35(8):668-73. doi: 10.1111/j.1600-051X.2008.01249.x. Epub 2008 Jun 28.
  73. Monsarrat P, Vergnes JN, Blaizot A, et al. Oral health status in outpatients with rheumatoid arthritis: the OSARA study. Oral Health Dent Manag. 2014 Mar;13(1):113-9.
  74. Garner E, Reddy MS, Bridges SL, et al. Periodontal inflamed surface area is correlated to Rheumatoid Arthritis symptoms. J Dent Res 2014;93(Spec Iss. A): Abstract #1269.
  75. Savioli C, Ribeiro AC, Fabri GM, et al. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis. J Clin Rheumatol. 2012 Jun;18(4):180-4. doi: 10.1097/RHU.0b013e31825828be.
  76. Scher JU, Bretz WA, Abramson SB. Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors? Curr Opin Rheumatol. 2014 Jul;26(4):424-9. doi: 10.1097/BOR.0000000000000076.
  77. Chen HH, Chen DY, Lai KL, et al. Periodontitis and etanercept discontinuation risk in anti-tumor necrosis factor-naive rheumatoid arthritis patients: a nationwide population-based cohort study. J Clin Rheumatol. 2013 Dec;19(8):432-8. doi: 10.1097/RHU.0000000000000041.
  78. Paquette DW, Williams RC, Offenbacher S, et al. Long-term aspirin use and periodontitis: cross-sectional human study. J Dent Res 2005;84(Spec Iss. A): Abstract #1534.
  79. Williams RC, Jeffcoat MK, Howell TH, et al. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol. 1989 Sep;60(9):485-90. doi: 10.1902/jop.1989.60.9.485.
  80. Geisinger ML, Holmes CM, Vassilopoulos PJ, et al. Adjunctive Treatment of Chronic Periodontitis with Systemic Low-Dose Aspirin Therapy. Clin Adv Periodontol 2012;2(3):195-199. doi 10.1902/cap.2012.120022. Accessed January 10, 2017.
  81. Drouganis A, Hirsch R. Low-dose aspirin therapy and periodontal attachment loss in ex- and non-smokers. J Clin Periodontol. 2001 Jan;28(1):38-45.
  82. Shiloah J, Bland PS, Scarbecz M, et al. The effect of long-term aspirin intake on the outcome of non-surgical periodontal therapy in smokers: a double-blind, randomized pilot study. J Periodontal Res. 2014 Feb;49(1):102-9. doi: 10.1111/jre.12085. Epub 2013 Apr 18.
  83. Lopez-Olivo MA, Siddhanamatha HR, Shea B, et al. Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2014 Jun 10;(6):CD000957. doi: 10.1002/14651858.CD000957.pub2.
  84. Ishchenko A, Lories RJ. Safety and efficacy of biologic disease-modifying antirheumatic drugs in older rheumatoid arthritis patients: staying the distance. Drugs Aging. 2016 Jun;33(6):387-98. doi: 10.1007/s40266-016-0374-1.
  85. Galvao TF, Zimmermann IR, da Mota LM, et al. Withdrawal of biologic agents in rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol. 2016 Jul;35(7):1659-68. doi: 10.1007/s10067-016-3285-y. Epub 2016 Apr 23.
  86. Mesa F, Magán-Fernández A, Muñoz R, et al. Catecholamine metabolites in urine, as chronic stress biomarkers, are associated with higher risk of chronic periodontitis in adults. J Periodontol. 2014 Dec;85(12):1755-62. doi: 10.1902/jop.2014.140209.
  87. Breivik T, Gundersen Y, Gjermo P, et al. Chronic treatment with the glucocorticoid receptor antagonist RU486 inhibits diabetes-induced enhancement of experimental periodontitis. J Periodontal Res. 2014 Feb;49(1):36-44. doi: 10.1111/jre.12076. Epub 2013 Apr 16.
  88. Kaur S, Bright R, Proudman SM, et al. Does periodontal treatment influence clinical and biochemical measures for rheumatoid arthritis? A systematic review and meta-analysis. Semin Arthritis Rheum. 2014 Oct;44(2):113-22. doi: 10.1016/j.semarthrit.2014.04.009. Epub 2014 Apr 28.
  89. Bıyıkoğlu B, Buduneli N, Aksu K, et al. Periodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients. Rheumatol Int. 2013 Oct;33(10):2607-16. doi: 10.1007/s00296-013-2781-5. Epub 2013 Jun 1.
  90. Ortiz P, Bissada NF, Palomo L, et al. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol. 2009 Apr;80(4):535-40. doi: 10.1902/jop.2009.080447.
  91. Al-Katma MK, Bissada NF, Bordeaux JM, et al. Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol. 2007 Jun;13(3):134-7. doi: 10.1097/RHU.0b013e3180690616.
  92. Roman-Torres CV, Neto JS, Souza MA, et al. An Evaluation of Non-Surgical Periodontal Therapy in Patients with Rheumatoid Arthritis. Open Dent J. 2015 May 15;9:150-3. doi: 10.2174/1874210601509010150. eCollection 2015.
  93. Monsarrat P, Vergnes JN, Cantagrel A, et al. Effect of periodontal treatment on the clinical parameters of patients with rheumatoid arthritis: study protocol of the randomized, controlled ESPERA trial. Trials. 2013 Aug 14;14:253. doi: 10.1186/1745-6215-14-253.
  94. Nesse W, Linde A, Abbas F, et al. Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics. J Clin Periodontol. 2009 Apr;36(4):295-300. doi: 10.1111/j.1600-051X.2009.01377.x. Epub 2009 Mar 11.
  95. Cetinkaya B, Guzeldemir E, Ogus E, et al. Proinflammatory and anti-inflammatory cytokines in gingival crevicular fluid and serum of patients with rheumatoid arthritis and patients with chronic periodontitis. J Periodontol. 2013 Jan;84(1):84-93. doi: 10.1902/jop.2012.110467. Epub 2012 Mar 13.
  96. Silosi I, Cojocaru M, Foia L, et al. Significance of circulating and crevicular matrix metalloproteinase-9 in rheumatoid arthritis-chronic periodontitis association. J Immunol Res. 2015;2015:218060. doi: 10.1155/2015/218060. Epub 2015 Mar 3.
  97. Garner EM, Hardy SL, Holmes CM, et al. Decision Making in the Treatment of Patients With Rheumatoid Arthritis and Periodontitis: Scientific Evidence and Clinical Experience. Clin Adv Periodontol 2016;6(4):208-214. doi: 10.1902/cap.2016.160021. Accessed January 10, 2017.

Additional Resources

  • No Additional Resources Available